| 1 |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al. · Autophagy
Open access2,467 authors |
2 Jan 2016 |
6,023 |
| 2 |
Ferroptosis: past, present and future
Jie Li, Feng Cao, He-liang Yin et al. · Cell Death and Disease
Open access |
3 Feb 2020 |
4,259 |
| 3 |
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al. · The Lancet Oncology
|
25 Jul 2011 |
4,126 |
| 4 |
Prevalence of Diabetes among Men and Women in China
Wenying Yang, Juming Lu, Jianping Weng et al. · New England Journal of Medicine
|
24 Mar 2010 |
3,065 |
| 5 |
CellMarker: a manually curated resource of cell markers in human and mouse
Xinxin Zhang, Yujia Lan, Jinyuan Xu et al. · Nucleic Acids Research
Open access |
25 Sep 2018 |
1,765 |
| 6 |
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study
Yongze Li et al. · BMJ
Open access |
28 Apr 2020 |
1,672 |
| 7 |
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Mengyuan Li, Lin Li, Yue Zhang et al. · Infectious Diseases of Poverty
Open access |
28 Apr 2020 |
1,647 |
| 8 |
miR2Disease: a manually curated database for microRNA deregulation in human disease
Qinghua Jiang, Yadong Wang, Yangyang Hao et al. · Nucleic Acids Research
Open access |
16 Oct 2008 |
1,448 |
| 9 |
Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients
Zhixiang Shen, Guoqiang Chen, Jian-Hua Ni et al. · Blood
|
May 1997 |
1,440 |
| 10 |
CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data
Congxue Hu, Tengyue Li, Yingqi Xu et al. · Nucleic Acids Research
Open access |
11 Oct 2022 |
1,346 |
| 11 |
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Joyce W. Lustbader et al. · Science
|
15 Apr 2004 |
1,301 |
| 12 |
Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platform
Weitao Shen, Ziguang Song, Xiao Yan Zhong et al. · iMeta
Open access |
8 Jul 2022 |
1,236 |
| 13 |
CancerSEA: a cancer single-cell state atlas
Huating Yuan, Min Yan, Guanxiong Zhang et al. · Nucleic Acids Research
Open access |
8 Oct 2018 |
1,181 |
| 14 |
Synthesis of Copper Peroxide Nanodots for H 2 O 2 Self-Supplying Chemodynamic Therapy
Lisen Lin, Tao Huang, Jibin Song et al. · Journal of the American Chemical Society
|
2 Jun 2019 |
1,155 |
| 15 |
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
Zhenggang Ren et al. · The Lancet Oncology
|
15 Jun 2021 |
1,154 |
| 16 |
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2
Baofeng Yang, Huixian Lin, Jiening Xiao et al. · Nature Medicine
|
Apr 2007 |
1,149 |
| 17 |
Characterization of human plasma-derived exosomal RNAs by deep sequencing
Xiaoyi Huang, Tiezheng Yuan, Michael Tschannen et al. · BMC Genomics
Open access |
10 May 2013 |
1,085 |
| 18 |
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou et al. · Signal Transduction and Targeted Therapy
Open access |
20 Jun 2022 |
1,069 |
| 19 |
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
Jie Li et al. · The Lancet. Gastroenterology & hepatology
Review |
19 Mar 2019 |
1,067 |
| 20 |
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Long Zhou et al. · Cell Host & Microbe
Open access |
4 May 2020 |
1,046 |
| 21 |
A Human Genome Diversity Cell Line Panel
Howard M. Cann et al. · Science
|
12 Apr 2002 |
1,046 |
| 22 |
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R.D. Johnston et al. · Journal of Clinical Oncology
Open access |
20 Sep 2020 |
1,037 |
| 23 |
The role of JAK/STAT signaling pathway and its inhibitors in diseases
Ping Xin, Xiaoyun Xu, Chengjie Deng et al. · International Immunopharmacology
|
20 Jan 2020 |
1,008 |
| 24 |
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang et al. · Molecular Cancer
Open access |
11 Mar 2023 |
977 |
| 25 |
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Hao Sun et al. · The Lancet Oncology
|
29 Sep 2016 |
972 |
| 26 |
Sparse whole-genome sequencing identifies two loci for major depressive disorder
Na Cai et al. · Nature
Open access108 authors |
14 Jul 2015 |
927 |
| 27 |
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang et al. · The Lancet
Open access |
Jun 2023 |
905 |
| 28 |
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Mei Yao et al. · Signal Transduction and Targeted Therapy
Open access |
20 Mar 2023 |
879 |
| 29 |
In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients With Acute Coronary Syndrome by Intravascular Optical Coherence Tomography
Haibo Jia et al. · Journal of the American College of Cardiology
Open access |
27 Jun 2013 |
858 |
| 30 |
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
Jian Zhou et al. · Liver Cancer
Open access |
2020 |
848 |
| 31 |
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Hui Luo et al. · JAMA
Open access |
14 Sep 2021 |
842 |
| 32 |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
Jin Li, Shukui Qin, Rui‐Hua Xu et al. · The Lancet Oncology
|
13 May 2015 |
826 |
| 33 |
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A. Michael Lincoff et al. · New England Journal of Medicine
Open access |
17 May 2017 |
817 |
| 34 |
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
Liwen Xu, Chunyu Deng, Bo Pang et al. · Cancer Research
|
28 Aug 2018 |
810 |
| 35 |
Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery
Liwang Shi, Jinqiu Zhang, Man Zhao et al. · Nanoscale
Open access |
2021 |
809 |
| 36 |
Mitochondrial Fission Inhibitors Suppress Endothelin-1-Induced Artery Constriction
Chang Chen, Jin‐Lai Gao, Mingyu Liu et al. · Cellular Physiology and Biochemistry
Open access |
2017 |
782 |
| 37 |
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Weili Zhang et al. · New England Journal of Medicine
|
30 Aug 2021 |
777 |
| 38 |
Standards of medical care for type 2 diabetes in China 2019
Weiping Jia et al. · Diabetes/Metabolism Research and Reviews
Open access |
25 Mar 2019 |
772 |
| 39 |
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
Lorenz Räber et al. · European Heart Journal
Open access |
16 May 2018 |
763 |
| 40 |
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Simon I Hay et al. · The Lancet
Open access2,780 authors |
Oct 2025 |
762 |
| 41 |
Effect of Salt Substitution on Cardiovascular Events and Death
Bruce Charles Neal et al. · New England Journal of Medicine
Open access |
29 Aug 2021 |
745 |
| 42 |
Glioma targeted therapy: insight into future of molecular approaches
Keyang Yang, Zhijing Wu, Hao Zhang et al. · Molecular Cancer
Open access |
8 Feb 2022 |
738 |
| 43 |
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
Q-z Tuo et al. · Molecular Psychiatry
Open access |
8 Sep 2017 |
736 |
| 44 |
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
David Planchard et al. · New England Journal of Medicine
Open access |
8 Nov 2023 |
729 |
| 45 |
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
Shukui Qin et al. · The Lancet
Open access138 authors |
24 Jul 2023 |
729 |
| 46 |
Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer
Jiang Yu et al. · JAMA
Open access |
28 May 2019 |
725 |
| 47 |
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
Yelena Yuriy Janjigian, Akihito Kawazoe, Patricio Eduardo Yanez et al. · Nature
Open access |
15 Dec 2021 |
723 |
| 48 |
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al. · European Urology
Open access |
14 Aug 2014 |
711 |
| 49 |
The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer
Mingxia Jiang, Ling Qi, Lisha Li et al. · Cell Death Discovery
Open access |
28 Oct 2020 |
701 |
| 50 |
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
Sun Young Rha et al. · The Lancet Oncology
Open access228 authors |
21 Oct 2023 |
698 |